Inmed Pharmaceuticals Inc (INM)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Inmed Pharmaceuticals Inc-Aktie (INM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	26.78% 0.8202	1.1201	1.3047	1.2616	1.1117
Cost Of Revenue	11.29% 0.636	0.717	0.7281	1.086	0.6508
Gross Profit	54.31% 0.1842	0.4032	0.5767	0.1756	0.4609
Operating Expenses	2.83% 2.2868	2.2238	2.3967	2.3131	2.7149
Benefits Costs and Expenses	0.05% 2.8484	2.847	3.093	3.3825	3.6867
Costs And Expenses	0.05% 2.8484	2.847	3.093	3.3825	3.6867
Depreciation and Amortization	0.00% 0.0532	0.0532	0.0528	0.0523	0.0532
Operating Income/Loss	32.88% -1.4666	-1.1037	-1.0919	-1.0515	-1.6032
Income/Loss From Continuing Operations Before Tax	17.45% -2.0282	-1.7269	-1.7883	-2.1209	-2.575
Income/Loss From Continuing Operations After Tax	17.45% -2.0282	-1.7269	-1.7883	-2.1209	-2.575
Net Income/Loss	17.45% -2.0282	-1.7269	-1.7883	-2.1209	-2.575
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.00% 3.9545	3.9545	0.1721	1.096	0.7065
Diluted Average Shares	0.00% 3.9545	3.9545	0.1721	1.096	0.7065
Basic Earnings Per Share	15.91% -0.51	-0.44	-0.43	-1.94	-3.64
Diluted Earnings Per Share	15.91% -0.51	-0.44	-0.43	-1.94	-3.64
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$22.94

1.15%

RGC

$23.23

3.21%

RDY

$14.13

1.53%

NBIX

$129.78

1.57%

VTRS

$13.51

2.10%

UTHR

$536.12

0.62%